VIVSIXGO
Live / Allowed — Published for opposition (as of 13 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99171000
- Mark type
- Stylized text
- Filed
- 06 May 2025
- Published for opposition
- 02 Sept 2025
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 20 Mar 2026 — POST PUBLICATION AMENDMENT - ENTERED
- 20 Mar 2026 — ASSIGNED TO PETITION STAFF
- 12 Mar 2026 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 21 Jan 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 25 Sept 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 02 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Sept 2025 — PUBLISHED FOR OPPOSITION
- 27 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jul 2025 — ASSIGNED TO EXAMINER
- 06 May 2025 — APPLICATION FILING RECEIPT MAILED
- 06 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 May 2025 — NEW APPLICATION ENTERED